The aggressive molecular profile observed in our patient aligns well with previously reported leukemic DLBCL cases that commonly feature MYC and BCL-6 rearrangements, emphasizing the significance of prompt and comprehensive genetic evaluation in such atypical presentations.[6,7]. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.